Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ERβ modulators(Estrogen receptor beta modulators), NR1D1 modulators(Nuclear receptor subfamily 1 group D member 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H24F6N2O2S |
InChIKeyNECDAWXLCJDWTH-JOCHJYFZSA-N |
CAS Registry2756883-91-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Sclerosis | Preclinical | US | 27 Oct 2023 | |
Multiple Sclerosis | Preclinical | CN | 27 Oct 2023 |